Enovis Corp. (ENOV)
23.96
+0.28
(+1.18%)
USD |
NYSE |
Jun 09, 16:00
24.02
+0.06
(+0.23%)
Pre-Market: 20:00
Enovis SG&A Expense (Quarterly) : 282.81M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Neogen Corp. | 98.50M |
| Zimmer Biomet Holdings, Inc. | 849.90M |
| Edwards Lifesciences Corp. | 522.20M |
| IDEXX Laboratories, Inc. | 294.36M |
| Intuitive Surgical, Inc. | 613.30M |